Journal List > J Korean Ophthalmol Soc > v.54(6) > 1009704

Chun and Park: Comparison of Mean Deviation Between Integrated Binocular Visual Field and Monocular Visual Field

Abstract

Purpose

To compare the mean deviation (MD) between monocular and integrated binocular visual field (BVF).

Methods

Thirty-six patients with glaucoma in at least 1 eye were recruited for the present study. Seventy-two threshold sensitivities of the BVF were obtained without additional visual field test by the Best Location and Binocular Summation methods using the 2 monocular visual fields of central 30 o. The MD of the BVF was obtained by comparison to the value distribution in the age-matched population with normal BVF. After defining the better eye with the better MD value from the 2 eyes, comparison of the MDs between individual eyes and the integrated BVF were assessed. In addition, the MDs be-tween the integrated BVF and actual BVF were compared in 11 patients.

Results

In patients with a mean age of 58.7 years, the MD of the better eye was -2.3 dB, and the worse eye was -4.9 dB (p < 0.01). There was a significant difference between the 2 MDs derived from Best Location and Binocular Summation (-1.7 and -2.0 dB, respectively p = 0.045). The MDs according to BVF more improved than the better eye (p < 0.01 for both). There was no significant difference in MDs between integrated BVF and actual BVF (-1.9 vs -2.0, -2.3 vs -2.0, re-spectively p > 0.1).

Conclusions

The integrated BVF more improved than the better eye. When providing guidance to glaucoma patients re-garding therapeutic decisions considering the MD of IVF may be important.

References

1. Kass MA, Heuer DK, Higginbotham EJ. . The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma. Arch Ophthalmol. 2002; 120:701–13.
2. Miglior S, Zeyen T, Pfeiffer N. . Results of the European Glaucoma Prevention Study. Ophthalmology. 2005; 112:366–75.
3. Gupta N, Krishnadev N, Hamstra SJ, Yücel YH. Depth perception deficits in glaucoma suspects. Br J Ophthalmol. 2006; 90:979–81.
crossref
4. Ramulu PY, West SK, Munoz, B. . Driving cessation and driving limitation in glaucoma: the Salisbury Eye Evaluation Project. Ophthalmology. 2009; 116:1846–53.
5. McGwin G Jr, Xie A, Mays A. . Visual field defects and the risk of motor vehicle collisions among patients with glaucoma. Invest Ophthalmol Vis Sci. 2005; 46:4437–41.
6. Patino CM, McKean-Cowdin R, Azen SP. . Central and periph-eral visual impairment and the risk of falls and falls with injury. Ophthalmology. 2010; 117:199–206.
crossref
7. Gutierrez P, Wilson MR, Johnson C. . Influence of glaucoma-tous visual field loss on health-related quality of life. Arch Ophthalmol. 1997; 115:777–84.
crossref
8. Janz NK, Wren PA, Lichter PR. . Quality of life in newly diag-nosed glaucoma patients : The Collaborative Initial Glaucoma Treatment Study. Ophthalmology. 2001; 108:887–97.
9. McKean-Cowdin R, Wang Y, Wu J. . Impact of visual field loss on health-related quality of life in glaucoma: the Los Angeles Latino Eye Study. Ophthalmology. 2008; 115:941–8.e1.
10. Parrish RK 2nd, Gedde SJ, Scott IU. . Visual function and quality of life among patients with glaucoma. Arch Ophthalmol. 1997; 115:1447–55.
crossref
11. van Gestel A, Webers CA, Beckers HJ. . The relationship be-tween visual field loss in glaucoma and health-related qual-ity-of-life. Eye (Lond). 2010; 24:1759–69.
crossref
12. Varma R, Wu J, Chong K. . Impact of severity and bilaterality of visual impairment on health-related quality of life. Ophthalmology. 2006; 113:1846–53.
crossref
13. Friedman DS, Freeman E, Munoz B. . Glaucoma and mobility performance: the Salisbury Eye Evaluation Project. Ophthalmology. 2007; 114:2232–7.
14. Owen VM, Crabb DP, White ET. . Glaucoma and fitness to drive: using binocular visual fields to predict a milestone to blindness. Invest Ophthalmol Vis Sci. 2008; 49:2449–55.
crossref
15. Jampel HD, Friedman DS, Quigley H, Miller R. Correlation of the binocular visual field with patient assessment of vision. Invest Ophthalmol Vis Sci. 2002; 43:1059–67.
16. Crabb DP, Viswanathan AC, McNaught AI. . Simulating bin-ocular visual field status in glaucoma. Br J Ophthalmol. 1998; 82:1236–41.
crossref
17. Nelson-Quigg JM, Cello K, Johnson CA. Predicting binocular vis-ual field sensitivity from monocular visual field results. Invest Ophthalmol Vis Sci. 2000; 41:2212–21.
18. Crabb DP, Fitzke FW, Hitchings RA, Viswanathan AC. A practical approach to measuring the visual field component of fitness to drive. Br J Ophthalmol. 2004; 88:1191–6.
crossref
19. Legge GE. Binocular contrast summation–II. Quadratic summation. Vision Res. 1984; 24:385–94.
20. Anderson DR. The single field printout with Statpac analysis. Kist K, ed. Automated Static Perimetry. St. Louis: MO Mosby;1992; 84.
21. Esterman B. Functional scoring of the binocular field. Ophthalmology. 1982; 89:1226–34.
crossref
22. Jampel HD. Glaucoma patients' assessment of their visual function and quality of life. Trans Am Ophthalmol Soc. 2001; 99:301–17.
crossref
23. Mills RP. Correlation of quality of life with clinical symptoms and signs at the time of glaucoma diagnosis. Trans Am Ophthalmol Soc. 1998; 96:753–812.
24. Campbell FW, Green DG. Monocular versus binocular visual acuity. Nature. 1965; 208:191–2.
crossref
25. Meese TS, Georgeson MA, Baker DH. Binocular contrast vision at and above threshold. J Vis. 2006; 6:1224–43.
crossref
26. Simpson WA, Manahilov V, Shahani U. Two eyes: square root 2 better than one? Acta Psychol (Amst). 2009; 131:93–8.
27. Asaoka R, Crabb DP, Yamashita T. . Patients have two eyes!: binocular versus better eye visual field indices. Invest Ophthalmol Vis Sci. 2011; 52:7007–11.
crossref

Figure 1.
Schematic representation of the left (A), right (B), in-tegrated binocular visual field (BVF) by best location (D), BVF by binocular summation (E), and actual binocular visual field test (E). Four points (black squares of BVF) corresponding to the blind spots of both eyes without correlation between the right eye and left eye were excluded and threshold sensitivities of BVF were integrated from right and left eyes. VF (visual field).
jkos-54-919f1.tif
Figure 2.
Boxplot for the mean deviations of the integrated binocular visual field (BVF) by best location and binocular summation, the better and worse eye visual fields.
jkos-54-919f2.tif
Table 1.
Demographic and clinical characteristics of the patient and control groups in the study
Patient group Control group p-value*
Number of included subjects 36 30
Age (year) 58.7 ± 8.9 59.3 ± 10.2 0.194
Sex (F/M) (n (%)) 19 (52.8)/17 (47.2) 17 (56.7)/13 (43.3) 0.282
IOP (mm Hg) 14.8 ± 3.8 15.0 ± 2.5 0.420
Follow-up (year) 3.8 ± 1.3 1.2 ± 0.4 <0.01
Total number of VF (pairs) 72 (36) 60 (30)
MD of right VF, dB -4.4 ± 3.5 (-5.9, -3.1, -1.9) -0.3 ± 1.3 (-1.1, -0.3, 0.7) <0.01
MD of left VF, dB -2.9 ± 2.4 (-4.1, -1.9, -1.7) -0.4 ± 1.5 (-1.3, -0.6, 1.0) <0.01

Values are presented as mean ± SD.

MD = mean deviation; VF = visual field.

* p-value by Mann Whiney U test;

Intraocular pressure of both eyes;

Non-normally distributed variables.

Table 2.
Mean deviation on visual field of the patient group (n = 36)
Mean deviation, dB* p-value p-value
Right VFs -4.4 ± 3.5 (-5.9, -3.1, -1.9) <0.01 <0.01
Left VFs -2.9 ± 2.4 (-4.1, -1.9, -1.7) <0.01 <0.01
BVF by best location -1.7 ± 1.4 (-2.5, -1.5, -0.9) 0.045
BVF by binocular summation -2.0 ± 1.6 (-2.9, -1.9, -1.0) 0.045
The better eye -2.3 ± 2.0 (-3.0, -1.9, -1.5) 0.035 <0.01
The worse eye -4.9 ± 3.4 (-7.0, -3.6, -2.2) <0.01 <0.01

Values are presented as mean ± SD.

MD = mean deviation; VF = visual field; BVF = integrated binocular visual field.

* Non-normally distributed variables;

For the pairwise comparison with the BVF by Best location using the Wilcoxon signed-rank test;

For the pairwise comparison with the BVF by Binocular summation using the Wilcoxon signed-rank test.

Table 3.
Comparison of mean deviation between integrated BVF and actual BVF in the 11 patients
Mean deviation, dB* p-value
Actual BVF -2.0 ± 2.7 (-4.5, -2.0, 1.0)
BVF by best location -1.9 ± 2.4 (-4.3, -2.1, 0.4) 0.858
BVF by binocular summation -2.3 ± 2.7 (-5.1, -2.5, 0.3) 0.172

Values are presented as mean ± SD.

MD = mean deviation; VF = visual fiel; BVF = binocular visual field.

* Non-normally distributed variables;

For the pairwise comparison with the actual BVF using the Wilcoxon signed-rank test.

Table 4.
Mean deviation on visual field of the patient with glaucoma at both eyes or patients with glaucoma at only one eye
Mean deviation, dB* p-value p-value
Patients with glaucoma at both eyes (n = 14)
BVF by best location -2.3 ± 1.6 (-3.5, -2.1, -1.1) <0.01
BVF by binocular summation -2.7 ± 1.7 (-3.7, -2.4, -1.6) <0.01
The better eye -3.7 ± 2.4 (-5.6, -3.4, -1.9) 0.036 0.041
The worse eye -6.7 ± 3.6 (-8.8, -5.9, -3.5) <0.01 <0.01
Patients with glaucoma at only one eye (n = 22)
BVF by best location -1.3 ± 1.3 (-1.9, -1.2, -0.7) 0.038
BVF by binocular summation -1.4 ± 1.1 (-1.9, -1.7, -0.4) 0.038
The better eye -1.5 ± 1.3 (-2.2, -1.2, -0.8) <0.01 0.096
The worse eye -3.8 ± 2.7 (-5.1, -2.6, -2.0) <0.01 <0.01

Values are presented as mean ± SD.

MD = mean deviation; VF = visual field; BVF = integrated binocular visual field.

* Non-normally distributed variables;

For the pairwise comparison with the BVF by Best location using the Wilcoxon signed-rank test;

For the pairwise comparison with the BVF by Binocular summation using the Wilcoxon signed-rank test.

TOOLS
Similar articles